In response to the ongoing spread of the monkeypox virus, the American Medical Association (AMA) has released coding guidance for laboratory testing and vaccine administration. The new codes are effective for immediate use. The laboratory test describes the molecular diagnostic testing that detects the nucleic signature of an orthopoxvirus, while the vaccine codes describe the two smallpox and monkeypox virus products currently available.
87593: Infectious agent detection by nucleic acid (DNA or RNA); orthopoxvirus (eg, monkeypox virus, cowpox virus, vaccinia virus), amplified probe technique, each
90622: Vaccinia (smallpox) virus vaccine, live, lyophilized, 0.3 mL dosage, for percutaneous use
90611: Smallpox and monkeypox vaccine, attenuated vaccinia virus, live, non-replicating, preservative free, 0.5 mL dosage, suspension, for subcutaneous use
Full descriptors can be found on the AMA’s website. The AMA has also released a special edition CPT Assistant guide on monkeypox.
Visit the AAFP website to stay up to date on monkeypox.
— Erin Solis, manager of practice and payment, American Academy of Family Physicians
Posted on August 2, 2022, by Erin Solis
Disclaimer: The opinions and views expressed here are those of the authors and do not necessarily represent or reflect the opinions and views of the American Academy of Family Physicians. This blog is not intended to provide medical, financial, or legal advice. Some payers may not agree with the advice given. This is not a substitute for current CPT and ICD-9 manuals and payer policies. All comments are moderated and will be removed if they violate our Terms of Use.